Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Clin Exp Immunol ; 165(1): 104-9, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21501149

RESUMO

Pig xenografts represent an alternative source of organs for transplantation. Immunosuppression can prevent rejection, but involves high risk and cost. New anti-rejection techniques have been developed; however, results have not been successful. Few studies have reported xenoantibody levels in xenotransplanted patients with diabetes and no patients have reported a clinical correlation. We analysed anti-galactose (Gal) and other anti-pig antibody (APA) levels in xenotransplanted patients with type 1 diabetes and the relation to the clinical outcome. Twenty-three patients with type 1 diabetes were transplanted with porcine islets inside a device without immunosuppression. Demographic characteristics, insulin dose and xenoantibody levels at different periods were recorded. Anti-Gal and anti-pig antibodies were measured through indirect enzyme-linked immunosorbent assay (ELISA) and haemolytic anti-pig antibody assay. More than 50% were female; the mean current age, current diabetes duration, diabetes duration at xenotransplantation and time post-transplantation were: 20·8, 11, 5·5 and 5·7 years, respectively. Insulin doses remained with a mean reduction greater than 33% in more than 50% of the patients. The lowest anti-Gal antibody levels were related to the highest insulin dose reductions. This relationship could be explained by the device, Sertoli cells and accommodation process.


Assuntos
Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/terapia , Galactose/metabolismo , Insulina/metabolismo , Transplante das Ilhotas Pancreáticas , Adolescente , Animais , Animais Recém-Nascidos , Anticorpos Heterófilos/sangue , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/fisiopatologia , Equipamentos e Provisões , Feminino , Seguimentos , Galactose/imunologia , Sobrevivência de Enxerto/imunologia , Humanos , Tolerância Imunológica , Transplante das Ilhotas Pancreáticas/instrumentação , Transplante das Ilhotas Pancreáticas/métodos , Masculino , Recuperação de Função Fisiológica , Células de Sertoli/imunologia , Células de Sertoli/metabolismo , Células de Sertoli/patologia , Suínos , Transplante Heterólogo , Adulto Jovem
2.
Clin Exp Immunol ; 162(3): 537-42, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20964645

RESUMO

Pancreas transplantation is an option to achieve better metabolic control and decrease chronic complications in patients with diabetes. Xenotransplantation becomes an important alternative. In this study, we show the clinical outcome of patients with type 1 diabetes transplanted with neonatal pig islets without immunosuppression. In a longitudinal study of 23 patients with type 1 diabetes, who received porcine islets between 2000 and 2004, we registered demographic and clinical characteristics every 3 months and chronic complications evaluation yearly. Porcine C-peptide was measured in urine samples under basal conditions and after stimulation with l-arginine. More than 50% were female, median current age was 20·8 years, median diabetes duration at transplantation 5·5 years, median current diabetes duration 11 years and median time post-transplantation 5·7 years. Their media of glycosylated haemoglobin reduced significantly after the first transplantation. Insulin doses remain with a reduction greater than 33% in more than 50% of the patients. Before transplantation, 14 of the 21 patients presented mild chronic complications and currently only two patients presented these complications. Porcine C-peptide was present in all urine samples under basal conditions and increased post-stimulation with l-arginine. These patients achieved an excellent metabolic control after the first transplantation. This could explain, as well as the remaining function of transplanted cells, the low frequency of chronic complications compared to patients with similar diabetes duration and age.


Assuntos
Complicações do Diabetes/prevenção & controle , Diabetes Mellitus Tipo 1/terapia , Transplante das Ilhotas Pancreáticas , Adolescente , Animais , Animais Recém-Nascidos , Peptídeo C/urina , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 1/fisiopatologia , Progressão da Doença , Intervalo Livre de Doença , Feminino , Seguimentos , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Suínos , Fatores de Tempo , Transplante Heterólogo , Adulto Jovem
3.
Clin Transplant ; 21(3): 352-7, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17488384

RESUMO

In order to alleviate the shortage of human donors, the use of porcine islets of Langerhans for xenotransplantation in diabetic patients has been proposed as a solution. To overcome rejection, we have developed a procedure for protecting the islets by combining them with Sertoli cells and placing them in a novel subcutaneous device, that generates an autologous collagen covering. A type 1 diabetic woman was closely monitored for 10 months, and then transplanted in two devices with two months of difference and a third time after 22 months. Here we present a three-yr follow-up. The close monitoring induced a rapid decrease in exogenous insulin requirements, which stabilized between 19 and 28 IU/d for nine months. After transplantation, the requirements reduced further to below 6 IU/d and for some weeks she was insulin free. Glycosylated hemoglobin levels decreased concomitantly. Porcine insulin could be detected in the serum after a glucose challenge and insulin positive cells inside a removed device after two yr. No complications have arisen and no porcine endogenous retrovirus infection has been detected through PCR and RT-PCR. This case demonstrates the feasibility of using the xenotransplantation of porcine cells to alleviate metabolic complications and insulin requirements in type 1 diabetic patients.


Assuntos
Diabetes Mellitus Tipo 1/cirurgia , Transplante das Ilhotas Pancreáticas/métodos , Transplante Heterólogo , Adolescente , Animais , Hormônio Antimülleriano , Feminino , Seguimentos , Teste de Tolerância a Glucose , Hemoglobinas Glicadas/análise , Glicoproteínas/análise , Humanos , Imuno-Histoquímica , Insulina/administração & dosagem , Suínos , Hormônios Testiculares/análise
4.
Arch Dis Child ; 61(7): 666-70, 1986 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3740906

RESUMO

Four children with juvenile osteopetrosis are described who were treated with a combination of prednisone and a low calcium, high phosphate diet. One of the children, treated as a neonate, achieved complete clinical and radiological remission from the disease after nine months, at which point treatment was stopped. There have been no signs of recurrence for two years. Two who did not start treatment until over 24 months of age have shown a good clinical and radiological response but have remained on treatment for six years. The fourth child started treatment at 6 months and showed a good clinical response, but x ray films showed no change nine months later. He was then lost to follow up, stopped treatment, and died two years later of a septicaemia. These patients provide further evidence for the efficacy of steroids in juvenile osteopetrosis, and the combination with the low calcium, high phosphate diet described offers a potentially effective alternative treatment to marrow transplantation, both for the haematological and skeletal complications of the disorder.


Assuntos
Cálcio da Dieta/administração & dosagem , Osteopetrose/terapia , Fosfatos/administração & dosagem , Prednisona/uso terapêutico , Estatura , Peso Corporal , Osso e Ossos/diagnóstico por imagem , Terapia Combinada , Feminino , Humanos , Lactente , Masculino , Osteopetrose/dietoterapia , Osteopetrose/tratamento farmacológico , Radiografia
6.
Bol. méd. Hosp. Infant. Méx ; 40(8): 417-23, 1983.
Artigo em Espanhol | LILACS | ID: lil-17941

RESUMO

La vitamina D, actualmente considera como hormona y sus metabolitos, intervienen en forma importante en el metabolismo mineral. Despues de formarse en la piel o adquirir-se en la dieta, la vitamina D sufre sucesivas hidroxilaciones en el higado y el rinon que convierten substancias inactivas en activas para el metabolismo mineral especialmente del calcio,de acuerdo a los sitios de hidroxilacion que se presentan. La carencia o trastorno del metabolismo de esta hormona trae como consequencia la aparicion de alteraciones esqueleticas denominadas raquitismo cuando se trata de individuos en crecimiento, caracterizada por un aumento del tejido osteoide y disminucion del frente de mineralizacion osea


Assuntos
Humanos , Raquitismo , Vitamina D
8.
J Lab Clin Med ; 91(5): 791-6, 1978 May.
Artigo em Inglês | MEDLINE | ID: mdl-641401

RESUMO

A protein-binding assay for determination of 25(OH)D was used to analyze the profile of chromatographed ethanol extracts of serum. There were substances in the serum of normal subjects which displaced labeled 25(OH)D3 from the binding protein and which were different from 25(OH)D or 24R,25(OH)2D. Values of 25(OH)D from serum samples without prior chromatography were higher than those obtained with chromatography (40.2 +/- 12.2 ng/ml vs. 22.3 +/- 8.2, mean +/- S.D.). This indicates a need for chromatography before assay to ensure specificity of 25(OH)D measurement.


Assuntos
Hidroxicolecalciferóis/isolamento & purificação , Ligação Competitiva , Cromatografia em Gel , Humanos , Hidroxicolecalciferóis/sangue , Ensaio Radioligante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...